These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29146641)

  • 41. Colorectal cancer in women: hormone replacement therapy and chemoprevention.
    Barnes EL; Long MD
    Climacteric; 2012 Jun; 15(3):250-5. PubMed ID: 22612611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A prospective study of menopausal hormones and risk of colorectal cancer (United States).
    Troisi R; Schairer C; Chow WH; Schatzkin A; Brinton LA; Fraumeni JF
    Cancer Causes Control; 1997 Mar; 8(2):130-8. PubMed ID: 9134236
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thyroid dysfunction, thyroid hormone replacement and colorectal cancer risk.
    Boursi B; Haynes K; Mamtani R; Yang YX
    J Natl Cancer Inst; 2015 Jun; 107(6):djv084. PubMed ID: 25855726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Postmenopausal Hormone Therapy and Breast Cancer Prognostic Characteristics: A Linkage between Nationwide Registries.
    Román M; Graff-Iversen S; Weiderpass E; Vangen S; Sakshaug S; Hofvind S; Ursin G
    Cancer Epidemiol Biomarkers Prev; 2016 Nov; 25(11):1464-1473. PubMed ID: 27461048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
    Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
    Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.
    Persson I; Yuen J; Bergkvist L; Schairer C
    Int J Cancer; 1996 Jul; 67(3):327-32. PubMed ID: 8707404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk of proximal and distal colorectal cancer following flexible sigmoidoscopy: a population-based cohort study.
    Rabeneck L; Lewis JD; Paszat LF; Saskin R; Stukel TA
    Am J Gastroenterol; 2008 Aug; 103(8):2075-82. PubMed ID: 18684198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short and long term effects of tibolone in postmenopausal women.
    Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study.
    Mikkola TS; Savolainen-Peltonen H; Tuomikoski P; Hoti F; Vattulainen P; Gissler M; Ylikorkala O
    Menopause; 2016 Nov; 23(11):1199-1203. PubMed ID: 27465718
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis: a nested case-control study in UK general practice.
    García Rodríguez LA; Soriano-Gabarró M; Bromley S; Lanas A; Cea Soriano L
    BMC Cancer; 2017 Sep; 17(1):637. PubMed ID: 28882113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a population-based case-control study.
    Tetsche MS; Jacobsen J; Nørgaard M; Baron JA; Sørensen HT
    Am J Gastroenterol; 2007 Feb; 102(2):275-8. PubMed ID: 17311649
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of hormone replacement therapy improves the prognosis in patients with colorectal cancer: A population-based study in Sweden.
    Ji J; Sundquist J; Sundquist K
    Int J Cancer; 2018 May; 142(10):2003-2010. PubMed ID: 29270993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
    Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
    Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition.
    Tsilidis KK; Allen NE; Key TJ; Sanjoaquin MA; Bakken K; Berrino F; Fournier A; Lund E; Overvad K; Olsen A; Tjønneland A; Byrnes G; Chajes V; Rinaldi S; Boutron-Ruault MC; Clavel-Chapelon F; Chang-Claude J; Kaaks R; Bergmann M; Boeing H; Koumantaki Y; Palli D; Pala V; Panico S; Tumino R; Vineis P; Bas Bueno-de-Mesquita H; van Duijnhoven FJ; van Gils CH; Peeters PH; Rodríguez L; González CA; Sánchez MJ; Chirlaque MD; Barricarte A; Dorronsoro M; Khaw KT; Rodwell SA; Norat T; Romaguera D; Riboli E
    Int J Cancer; 2011 Apr; 128(8):1881-9. PubMed ID: 20533550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.
    Söderlund S; Granath F; Broström O; Karlén P; Löfberg R; Ekbom A; Askling J
    Gastroenterology; 2010 May; 138(5):1697-703. PubMed ID: 20167217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study.
    Lund E; Bakken K; Dumeaux V; Andersen V; Kumle M
    Int J Cancer; 2007 Aug; 121(3):645-8. PubMed ID: 17372914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study.
    Limburg PJ; Vierkant RA; Fredericksen ZS; Leibson CL; Rizza RA; Gupta AK; Ahlquist DA; Melton LJ; Sellers TA; Cerhan JR
    Am J Gastroenterol; 2006 Aug; 101(8):1872-9. PubMed ID: 16790032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long term hormone therapy for perimenopausal and postmenopausal women.
    Farquhar CM; Marjoribanks J; Lethaby A; Lamberts Q; Suckling JA;
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004143. PubMed ID: 16034922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis.
    Grodstein F; Newcomb PA; Stampfer MJ
    Am J Med; 1999 May; 106(5):574-82. PubMed ID: 10335731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of various forms of postmenopausal hormone therapy on the risk of ovarian cancer--a population-based case control study from Finland.
    Koskela-Niska V; Pukkala E; Lyytinen H; Ylikorkala O; Dyba T
    Int J Cancer; 2013 Oct; 133(7):1680-8. PubMed ID: 23526244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.